After Biogen's earnings, SKYCLARYS (Reata's drug acquired for 7.3B USD) has made 100M USD (75.6M in the USA and 24.4M in ROW), in the USA in the 2Q it has made exactly the same as DAYBUE made in the 1Q (which for the market was disappointing)
Do the math!!!
https://investors.biogen.com/static-files/4c2f5ac9-7058-4b6f-81ef-11a2125c6698
After Biogen's earnings, SKYCLARYS (Reata's drug acquired for...
-
- There are more pages in this discussion • 129 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.56 |
Change
-0.360(2.59%) |
Mkt cap ! $1.733B | |||
| Open | High | Low | Value | Volume |
| $13.94 | $13.96 | $13.50 | $6.421M | 470.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1643 | $13.54 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.61 | 3100 | 1 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |